PyInvesting

Market research

003850.KO Boryung Pharmaceutical Co., Ltd

KO KRW Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
755B
P/E ratio
Not available
Analyst target
14000
Dividend yield
1.7%
Beta
0.3

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Boryung Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 18.0% above its 200 day moving average.

From a valuation standpoint, the stock is 79.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.

Boryung Pharmaceutical Co., Ltd's total revenue sank by 0.4% to $138B since the same quarter in the previous year.

Its net income has dropped by 16.6% to $4B since the same quarter in the previous year.

Finally, its free cash flow fell by 60.1% to $-7B since the same quarter in the previous year.

Based on the above factors, Boryung Pharmaceutical Co., Ltd gets an overall score of 2/5.